NCT06276998View on ClinicalTrials.gov

A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

August 4, 2025

Study Completion Date

November 20, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

LNK01001

Capsule; Oral

DRUG

Placebo

Capsule; Oral

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Lynk Pharmaceuticals Co., Ltd

INDUSTRY

NCT06276998 - A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter